Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, ...

The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...

The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

The Statesboro community is rallying behind U.S. Army veteran Matthew Kleinsorge, a devoted father of four, as he battles ...

Tumor-Induced B Cell Changes Reveal Potential Biomarker for Treatment Response in Triple ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

Carterville High School will hold an “Orange Out” fundraiser on Feb. 1 to support assistant coach and teacher Eli Gunther as ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.